Paramethadione
From Wikipedia, the free encyclopedia
Paramethadione
|
|
Systematic (IUPAC) name | |
5-ethyl-3,5-dimethyl-oxazolidine-2,4-dione | |
Identifiers | |
CAS number | |
ATC code | N03 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C7H11NO3 |
Mol. mass | 157.167 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | Not significant |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
D(US) |
Legal status | |
Routes | ? |
Paramethadione is an anticonvulsant in the oxazolidinedione class. It is associated with fetal trimethadione syndrome, which is also known as paramethadione syndrome.[1]
[edit] References
- ^ Multiple Congenital Anomaly/Mental Retardation (MCA/MR) Syndromes - Retrieved January 2007.
[edit] External links
- DDB 33106
- Hoffman, D; Chun A (1975). "Paramethadione and metabolite serum levels in humans after a single oral paramethadione dose". J Pharm Sci 64 (10): 1702–1703. doi: . PMID 1185541.